NYSE$CYH

Community Health Systems Inc · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

Community Health Systems, Inc. announced its financial and operating results for the fourth quarter and year ended December 31, 2024.

Community Health Systems, Inc. reported a net operating revenue of $3.265 billion for Q4 2024, a 2.6% increase from the previous year. The company experienced a net loss of $70 million, or $(0.53) per diluted share, compared to a net income of $46 million, or $0.35 per diluted share, in Q4 2023. Adjusted EBITDA increased to $428 million from $386 million in the prior year period.

  • Net operating revenues increased by 2.6% to $3.265 billion in Q4 2024.
  • The company reported a net loss of $70 million, or $(0.53) per diluted share, in Q4 2024.
  • Adjusted EBITDA for Q4 2024 was $428 million, an increase from $386 million in Q4 2023.
  • Same-store admissions increased by 3.4% and same-store adjusted admissions increased by 3.1% compared to Q4 2023.

Headline financials

Total Revenue

$3.27B

Previous: $3.18B+2.6%
EPS (adj)

-$0.42

Previous: -$0.41-2.4%
Capital Expenditures

-$109M

Previous: -$110M+0.9%
Free Cash Flow

$107M

Previous: -$20M+635.0%
Net Income

-$28M

Previous: $85M-132.9%
Operating Income

$279M

Previous: $327M-14.7%
Gross Profit

$286M

Previous: $1.31B-78.2%

Revenue & EPS history

CHS · Revenue · Quarterly

$3.27B

Q4 2024+2.6%vs Q4 2023
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Forward guidance

For the year ending December 31, 2025, Community Health Systems, Inc. projects net operating revenues between $12.2 billion and $12.6 billion, Adjusted EBITDA between $1.45 billion and $1.6 billion, and net loss per share (diluted) between $(0.55) and $0.00. Capital expenditures are projected to be between $350 million and $400 million, and net cash provided by operating activities is projected to be between $600 million and $700 million.

Tailwinds

  • Projections include the effect of completing divestitures for which definitive agreements have been executed.
  • Net income attributable to noncontrolling interests is projected to be approximately 1.2% to 1.3% of net operating revenues.
  • Provision for income taxes is projected to be approximately 1.0% to 1.1% of net operating revenues.
  • Diluted weighted-average shares outstanding are projected to be approximately 134 million for 2025.
  • Total fixed rate debt is expected to average approximately 97% of total debt during 2025.

Headwinds

  • Projections exclude the impact of any future divestitures for which definitive agreement(s) have not yet been executed.
  • Projections exclude the effect of debt refinancing activities, including gains and losses from early extinguishment of debt.
  • Projections exclude impairment of goodwill and long-lived assets.
  • Projections exclude gains or losses and associated tax impacts from the sales of businesses.
  • Projections exclude costs incurred in connection with divestitures.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+1.7%

Avg return

Earnings day

+3.6%

Avg return

5 days after

+2.4%

Avg return

30 days after

55%

38 / 69 earnings

Positive

+52.4%

Q4 2022

Best reaction

-41.0%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%+6.3%+3.0%
Q4 2025+5.7%+4.5%-13.5%
Q3 2025+25.8%+29.1%-4.3%
Q2 2025+0.0%-0.7%+7.7%
Q1 2025+18.5%+11.1%+51.0%
Q4 2024+7.8%+9.9%-22.4%
Q3 2024-22.6%-25.3%-33.5%
Q2 2024+17.5%+27.9%+24.9%
Q1 2024+9.8%+11.1%+20.9%
Q4 2023-28.4%-27.7%-11.6%
Q3 2023-7.0%-18.0%+12.1%
Q2 2023+11.8%-8.4%-18.9%
Q1 2023-39.9%-42.3%-48.4%
Q4 2022+52.4%+56.3%-0.6%
Q3 2022+36.8%+35.4%+68.9%
Q2 2022-41.0%-39.6%-38.6%
Q1 2022-4.2%-19.1%-40.1%
Q4 2021-10.1%-21.3%-15.1%
Q3 2021+19.1%+28.9%+28.4%
Q2 2021-6.4%-8.3%-13.1%
Q1 2021+0.3%+15.2%+37.9%
Q4 2020-7.6%-9.3%+28.3%
Q3 2020+19.2%+30.3%+78.3%
Q2 2020+14.2%+26.4%+37.8%
Q1 2020-7.4%-22.9%-11.8%
Q4 2019+42.7%+27.8%-44.2%
Q3 2019-17.0%-30.4%-32.6%
Q2 2019+12.9%+25.8%+39.7%
Q1 2019-1.7%-4.0%-19.9%
Q4 2018+12.8%+21.4%+8.5%
Q3 2018-6.3%+20.0%+33.3%
Q2 2018+2.3%+9.5%+16.7%
Q1 2018+34.7%+26.5%+8.2%
Q4 2017-11.6%-15.0%-31.6%
Q3 2017-23.1%-26.6%-26.3%
Q2 2017-7.8%-8.8%+6.9%
Q1 2017+19.9%+11.7%+2.8%
Q4 2016+33.8%+33.6%+21.7%
Q3 2016+0.8%+4.9%+3.0%
Q2 2016-1.5%-0.5%-19.3%
Q1 2016-22.1%
Q4 2015-22.1%
Q3 2015-2.4%
Q2 2015+1.2%
Q1 2015-7.6%
Q4 2014+1.2%
Q3 2014-5.0%
Q2 2014-4.9%
Q1 2014-7.2%
Q4 2013+0.3%
Q3 2013-0.3%
Q2 2013+2.2%
Q1 2013+4.7%
Q4 2012+1.4%
Q3 2012+2.4%
Q2 2012-4.3%
Q1 2012+5.2%
Q4 2011+5.3%
Q3 2011-2.7%
Q2 2011-6.4%
Q1 2010-3.5%
Q1 2011+0.1%
Q4 2008+8.0%
Q4 2010+8.0%
Q3 2009+2.0%
Q3 2010+2.0%
Q4 2009+4.3%
Q2 2009+4.3%
Q2 2010+4.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro